Price
CHART BY
Frequently asked questions
What is NeutriSci's market capitalization?
The market capitalization of NeutriSci is $592.58K. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for NeutriSci?
NeutriSci's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.002185. EPS indicates the company's profitability on a per-share basis.
What is NeutriSci's revenue over the trailing twelve months?
Over the trailing twelve months, NeutriSci reported a revenue of $42.28K.
What is the EBITDA for NeutriSci?
NeutriSci's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$375.43K. EBITDA measures the company's overall financial performance.
What is the free cash flow of NeutriSci?
NeutriSci has a free cash flow of -$186.57K. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the free float of NeutriSci's shares?
The free float of NeutriSci is 167.51M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $592.58K
- EPS (TTM)
- -$0.002185
- Free Float
- 167.51M
- Revenue (TTM)
- $42.28K
- EBITDA (TTM)
- -$375.43K
- Free Cashflow (TTM)
- -$186.57K
Pricing
- 52W span
- $0.003616$0.007313
Information
NeutriSci International, Inc. engages in the development, formulation, and production of products for the Nutraceutical and CBD/THC industries. Its products utilize a patented form of Pterostilbene called pTeroPure. The pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries, and is manufactured for the company by ChromaDex in the United States. The firm's products include NeuEnergy, which combines caffeine and the ingredient found in blueberries. The company was founded on September 9, 2009 and is headquartered in Vancouver, Canada.
- Industries
- Other Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- CA64129Y1079
- Primary Ticker
- NU
Knockouts
Finance data from FactSet